Mr. Terry Eugene Sullivan, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 470 Sullivan Rd, Makanda, IL 62958 Phone: 618-697-2861 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, forecasts that the type 2 diabetes market in Mexico will grow to $1.22 billion in 2014. Drivers of this growth include increasing prevalent population, expanding medical insurance coverage as well as the launch and use of new drugs in the market.
In an analysis that included more than 1.4 million births, exposure to magnetic resonance imaging (MRI) during the first trimester of pregnancy compared with nonexposure was not associated with increased risk of harm to the fetus or in early childhood, although gadolinium MRI at any time during pregnancy was associated with an increased risk of a broad set of rheumatological, inflammatory, or skin conditions and, possibly, for stillbirth or neonatal death, according to a study appearing in the September 6 issue of JAMA.
Amgen Inc. today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for denosumab, a subcutaneous RANK Ligand inhibitor. The BLA submission summarizes clinical experience from nearly 6,900 patients across 18 clinical studies, including approximately 5,700 patients with advanced cancer in the three, pivotal, Phase 3, head-to-head trials versus Zometa® (zoledronic acid).
A study published in the current issue of psychotherapy and psychosomatics provides data concerned with the prevalence of nightmares disorder in psychiatric patients.
When a patient arrives at an American emergency room today, they have a higher chance than ever before of seeing a doctor who's a woman or a person of color. And they're also more likely than ever to get a survey after they go home, asking how satisfied they were with their ER care.
› Verified 1 days ago